Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.68 |
| ▸ | DGKA | P23743 | 1/20 | 0.68 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.64 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.64 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.64 |
| ▸ | PRKCA | P17252 | 1/20 | 0.64 |
| ▸ | MGLL | Q99685 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.61 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.60 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.60 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.60 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12116640 | 1.00 | FAAH (0.68) | FAAHDGKAPRKCEPRKCQPRKCD | |
| SCHEMBL7029602 | 0.95 | FAAH (0.74) | FAAHDGKAPRKCEPRKCQPRKCD | |
| SCHEMBL7029598 | 0.95 | FAAH (0.74) | FAAHDGKAPRKCEPRKCQPRKCD | |
| SCHEMBL9169298 | 0.95 | DGKA (0.73) | FAAHDGKAPRKCEPRKCQPRKCD | |
| SCHEMBL10655057 | 0.95 | DGKA (0.73) | FAAHDGKAPRKCEPRKCQPRKCD | |
| SCHEMBL332985 | 0.95 | DGKA (0.73) | FAAHDGKAPRKCEPRKCQPRKCD | |
| SCHEMBL12438334 | 0.95 | DGKA (0.73) | FAAHDGKAPRKCEPRKCQPRKCD | |
| SCHEMBL3658169 | 0.95 | DGKA (0.73) | FAAHDGKAPRKCEPRKCQPRKCD | |
| SCHEMBL332986 | 0.95 | DGKA (0.73) | FAAHDGKAPRKCEPRKCQPRKCD | |
| SCHEMBL2396742 | 0.95 | DGKA (0.73) | FAAHDGKAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109438240-B | Preparation method of stable iodized linoleate | 季珉 | 2022-05-03 | — | — | CN | claimed |
| CN-109438240-A | A kind of preparation method of stable iodinated linoleic acid ester | 季珉 | 2019-03-08 | — | — | CN | claimed |
| US-9790387-B2 | Non-aqueous ink jet ink composition | SEIKO EPSON CORPORATION (JP) | 2017-10-17 | — | — | US | claimed |
| US-20160264804-A1 | NON-AQUEOUS INK JET INK COMPOSITION | SEIKO EPSON CORPORATION (JP) | 2016-09-15 | — | — | US | claimed |
| US-9028805-B2 | Conditioning composition for hair | KAO GERMANY GMBH (DE) | 2015-05-12 | — | — | US | claimed |
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | claimed |
| US-8048828-B2 | Spotting fluid compositions and associated methods | HALLIBURTON ENERGY SERVICES INC. (US) | 2011-11-01 | — | — | US | claimed |
| US-8048829-B2 | Spotting fluid compositions and associated methods | HALLIBURTON ENERGY SERVICES INC. (US) | 2011-11-01 | — | — | US | claimed |
| EP-2319895-A1 | Spotting fluid compositions and associated methods | Halliburton Energy Services, Inc. (US) | 2011-05-11 | — | — | EP | claimed |
| EP-1846531-B1 | SPOTTING FLUID COMPOSITIONS AND ASSOCIATED METHODS | HALLIBURTON ENERGY SERV INC (US) | 2011-03-16 | — | — | EP | claimed |
| WO-2006087505-A2 | SPOTTING FLUID COMPOSITIONS AND ASSOCIATED METHODS | HALLIBURTON ENERGY SERVICES, INC (US) | 2006-08-24 | — | — | WO | claimed |
| WO-2006077372-A1 | SPOTTING FLUID COMPOSITIONS AND ASSOCIATED METHODS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2006-07-27 | — | — | WO | claimed |
| US-20060160706-A1 | Spotting fluid compositions and associated methods | HALLIBURTON ENERGY SERVICES, INC. | 2006-07-20 | — | — | US | claimed |
| US-20060160705-A1 | Spotting fluid compositions and associated methods | HALLIBURTON ENERGY SERVICES, INC. | 2006-07-20 | — | — | US | claimed |
| EP-1651206-A1 | COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL CONDITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2006-05-03 | — | — | EP | claimed |
| US-7022172-B2 | Comprises non-volatile solvent; for ink jet printing; improved storage stability | RISO KAGAKU CORPORATION (JP) | 2006-04-04 | — | — | US | claimed |
| CN-1646032-A | Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight | PROCTER & GAMBLE (US) | 2005-07-27 | — | — | CN | claimed |
| WO-2005016332-A1 | COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL CONDITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2005-02-24 | — | — | WO | claimed |
| US-20050032892-A1 | Compositions, kits, and methods for treating gastrointestinal conditions | THE PROCTER & GAMBLE COMPANY (US) | 2005-02-10 | — | — | US | claimed |
| US-20030203004-A1 | Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight | PROCTER & GAMBLE COMPANY, THE | 2003-10-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203004-A1 | Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight | FABP2, FABP6, FABP4 | FAAH 150/4885DGKA 143/4885PRKCE 2117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.